These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 3465966)
21. [Immunologic subclassification of lymphoblastic leukemia in childhood. II. Immunologic phenotype, clinical picture and prognosis]. Kołecki P Acta Haematol Pol; 1986; 17(3-4):103-9. PubMed ID: 3473885 [No Abstract] [Full Text] [Related]
22. [The significance of immunofluorescence and rosette tests in the study of acute lymphoblastic leukemia in childhood]. Nosková J; Cáp J; Babusíková O Cesk Pediatr; 1984 Sep; 39(9):513-7. PubMed ID: 6391703 [No Abstract] [Full Text] [Related]
24. [Acute lymphoblastic leukemia with an abnormal T8 phenotype]. Blanco A; Guisasola JA; Valbuena C; Solís P; Villar A; Sánchez Villares E Sangre (Barc); 1984; 29(3):302-9. PubMed ID: 6237441 [No Abstract] [Full Text] [Related]
25. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55. Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266 [TBL] [Abstract][Full Text] [Related]
27. [Relation between immunological and morphological characteristics and the clinical course in children with acute lymphoblastic leukemia]. Kubíková A; Habancová M; Valnícek S Cas Lek Cesk; 1984 May; 123(19):578-82. PubMed ID: 6589048 [No Abstract] [Full Text] [Related]
28. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia. Morishima Y; Sao H; Ueda R; Morishita Y; Murase T; Kodera Y; Ohno R; Tahara T; Yoshikawa S; Kato Y Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834 [TBL] [Abstract][Full Text] [Related]
29. [Immunologic heterogeneity of acute lymphoblastic leukemia in children detected with xenogeneic antisera]. Baryshnikov AIu; Tupitsin NN; Morozova LF; Tumian BG; Kadagidze ZG Ter Arkh; 1983; 55(11):81-6. PubMed ID: 6581572 [No Abstract] [Full Text] [Related]
36. The heterogeneity of 5'-nucleotidase activity in lymphoblasts of acute lymphoblastic leukemia, demonstrated by an improved cytochemical method. Pangalis GA; Tsavaris NB; Roussou PA Biomed Pharmacother; 1984; 38(9-10):444-8. PubMed ID: 6099151 [TBL] [Abstract][Full Text] [Related]
37. [Surface markers of T and B lymphocytes: II. Their investigation in 13 patients with untreated acute lymphoblastic leukaemia (ALL) (author's transl)]. Tomić BL Lijec Vjesn; 1980 Dec; 102(12):689-93. PubMed ID: 7022076 [No Abstract] [Full Text] [Related]
38. Immunological identification of peripheral-blood lymphocytes from patients with lymphoproliferative disorders in Nigeria. II. Chronic lymphocytic leukaemia (CLL). Ukaejiofo EO; Sagoe AS; Osunkoya BO Afr J Med Med Sci; 1983; 12(3-4):197-202. PubMed ID: 6326554 [TBL] [Abstract][Full Text] [Related]
39. The evaluation of prognostic value of immunological markers in acute lymphoblastic leukemia (ALL) after intensification of treatment schedule. Bogusławska-Jaworska J; Rodziewicz B Arch Immunol Ther Exp (Warsz); 1986; 34(4):392-5. PubMed ID: 3492185 [TBL] [Abstract][Full Text] [Related]
40. [Prospective study of the immunologic classification of 128 cases of acute lymphoblastic leukemia in the city of Puebla, Mexico]. Ruiz-Argüelles GJ; Marín-López A; Ruiz-Argüelles A; Valls de Ruiz M; Pérez-Romano B; Ruiz-González DS Rev Invest Clin; 1987; 39(2):137-42. PubMed ID: 3310166 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]